Education, Science, Technology, Innovation and Life
Open Access
Sign In

Research Progress on the Mechanism of Radix Salviae Miltiorrhizae on Atherosclerosis

Download as PDF

DOI: 10.23977/medcm.2024.060106 | Downloads: 6 | Views: 173

Author(s)

Bingyu Yang 1, Zhen Ma 2

Affiliation(s)

1 Shaanxi University of Traditional Chinese Medicine, Xianyang, Shaanxi, 712046, China
2 Xi'an Traditional Chinese Medicine Hospital, Xi'an, Shaanxi, 710021, China

Corresponding Author

Zhen Ma

ABSTRACT

Predecessors said that "blindly Danshen Yin, Gongtong Siwu decoction", that is, the effect of promoting blood circulation of Salvia miltiorrhiza can be comparable to that of Angelica sinensis, Radix Rehmanniae, Radix Paeoniae Alba and Ligusticum chuanxiong. Modern Salvia miltiorrhiza is commonly used in the treatment of cerebrovascular and cardiovascular diseases, especially in anti-atherosclerosis, and the curative effect is remarkable, but the specific mechanism of its effect is not clear. Atherosclerosis refers to vascular endothelial injury, fibrous tissue hyperplasia and calcareous deposition, which accumulate in the intima, resulting in vascular wall thickening and hardening, vascular lumen stenosis, so it is important to intervene in the formation of atherosclerosis for clinical prevention and treatment of acute coronary syndrome. It's important to reduce mortality. This article focuses on the possible mechanism of Salvia miltiorrhiza in anti-atherosclerosis and provides new ideas for the treatment of atherosclerosis in the future.

KEYWORDS

Salvia Miltiorrhiza, Atherosclerosis, Platelet Aggregation, Inflammation, Oxidative Stress, Iron Death

CITE THIS PAPER

Bingyu Yang, Zhen Ma, Research Progress on the Mechanism of Radix Salviae Miltiorrhizae on Atherosclerosis. MEDS Chinese Medicine (2024) Vol. 6: 38-42. DOI: http://dx.doi.org/10.23977/medcm.2024.060106.

REFERENCES

[1] Lloyd-Jones DM, Larson MG, Leip EP, Beiser A, D Agostino RB, Kannel WB, Murabito JM, Vasan RS, Benjamin EJ, Levy D. Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation. 2002; 106(4):68-72
[2] Zhang Huimin, Zhuang Qingqi, Li Chengzhu, etc. Effect of sodium tanshinone Ⅱ-A sulfonate on Mg2+-ATP activity activated by platelet actin. Journal of Shanghai Medical University, 1988, (04): 289-292.
[3] Yang J, Dong J C, Li D Z, et al. The effect of Tanshinone II-Sodium A sulfonate on platelet functions in patienes with coronary heart disease. Journalof Traditional Chinese Medicine, 2013, 54(15): 1294-1296.
[4] Maione F, Cantone V, Chini M G, et al. Molecular mechanism of tanshinone IIA and crypto tanshinone in platelet antiaggregating effects: an integrted study of pharmacology and computational analysis. Fitoterapia, 2015, 100: 174-178.
[5] Zhang H M, Zhuang Q Q, Li C Z, et al. The effect of tanshinone II-A sulf Onate on actin activated Mg2+-ATP ase activity in platelets. Journal of Shanghai Medical University, 1988, 15(4): 289-292.
[6] Li Z, Li Q, Wang L, et al. Targeting mitochondria-inflammation circle by renal denervation reduces atheroprone endothelial phenotypes and atherosclerosis. Redox Biol. 2021; 47: 102156.
[7] Kong X L, Lyu Q, Zhang Y Q, et al. Effect of astragaloside IV and salvianolic acid B on antioxidant stress and vascular endothelial protection in the treatment of atherosclerosis based on metabonomics. Chin J Nat Med. 2022; 20(8): 601-613.
[8] Zhu Z, Li J, Zhang X. Astragaloside IV Protects Against Oxidized Low-Density Lipoprotein (ox-LDL)-Induced Endothelial Cell Injury by Reducing Oxidative Stress and Inflammation. Med Sci Monit. 2019; 25: 2132-2140.
[9] Zhang J, Wu C, Gao L, Du G, Qin X. Astragaloside IV derived from Astragalus membranaceus: A research review on the pharmacological effects. Adv Pharmacol. 2020; 87: 89-112.
[10] Yang TL, Lin FY, Chen YH, et al. Salvianolic acid B inhibits low-density lipoprotein oxidation and neointimal hyperplasia in endothelium-denuded hypercholesterolaemic rabbits. J Sci Food Agric. 2011; 91(1): 134-141.
[11] Medzhitov R. Origin and physiological roles of inflammation. Nature, 2008, 454(7203): 428-435.
[12] Medzhitov R. Inflammation 2010: new anventures of an old flam. Cell, 2010, 140(6): 771-776.
[13] De Torre-Minguela C, Mesa Del Castillo P, Pelegrin P. The NLRP3 and pyrin inflammasomes: implications in the pathophysiology of autoinflammatory diseases. Front Immunol, 2017, 8: 43.
[14] Wen H, Ting JP, O, Neill LA. Arole for the NLRP3 inflammasome inmetabolic diseses-did Warburg miss inflammation? Nat Immunol, 2012, 13(4):352-357
[15] Bai Y J, Lam H C, Lei X G. Dissecting programmed cell death withsmall molecules. Acc Chem Res, 2020, 53(5): 1034-1045.
[16] Dixon S J, Lemberg K M, Lamprecht M R, et al. Ferroptosis: an irondependent form of nonapoptotic cell death. Cell, 2012, 149(5): 1060-1072.
[17] Wang Y, Zhao Y, Wang H, et al. Histonedemethylase KDM3B protects against ferroptosis by upregulating SLC7A11.FEBS OpenBio, 2020, 10(4):637-643.
[18] Latunde-Dada GO. Ferroptosis: role of lipid peroxidation, iron andferritinophagy, Biochimica et biophysica acta. General Subjects, 2017, 1861(8):1893-1900.
[19] Kobayashi M, Suhara T, Baba Y, et al. Pathological roles of iron incardiovascular disease. Curr Drug Targets, 2018, 19(9):1068-1076.
[20] Kraml P. The role of iron in the pathogenesis of atherosclerosis. Physiol Res, 2017, 66(Suppl 1):s55-s67.
[21] Wu Yao, Song Nan, Jia Lianqun, etc. Effects of tanshinone Ⅱ An on lipid deposition and expression of iron death related proteins in liver of ApoE-/- mice. Chinese Journal of Pathophysiology, 2020, 36 (7): 1261-1268.
[22] Wang J, Xu J, Gong X, Yang M, Zhang C, Li M. Biosynthesis, Chemistry, and Pharmacology of Polyphenols from Chinese Salvia Species: A Review. Molecules.2019 Jan 2;24(1):155.

Downloads: 4192
Visits: 164882

Sponsors, Associates, and Links


All published work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2016 - 2031 Clausius Scientific Press Inc. All Rights Reserved.